Handheld X-ray system maker OXOS Medical scores $23M

0



Medical imaging firm OXOS Medical scored $23 million in Collection A funding from Intel Capital and Parkway Enterprise Capital, bringing its whole elevate to $45 million. 

Gregg Hill, Parkway’s cofounder and managing accomplice, and Eric King, Intel Capital’s funding director, will be part of OXOS’ board of administrators. 

WHAT THEY DO

The Atlanta-based firm affords an FDA 510(okay)-cleared handheld X-ray system that can be utilized for static and serial diagnostic pictures of the extremities, dubbed the Micro C Medical Imaging System. The system connects on to OXOS’ cloud platform, the place physicians can entry pictures.

The funds shall be used to develop the corporate’s product availability worldwide and pace up product innovation. 

“At OXOS, we now have made it our mission to shut the rising healthcare divide – the inaccessibility of radiographic know-how is impairing affected person outcomes in each nook of the globe,” Evan Ruff, cofounder and CEO of OXOS, stated in an announcement.

“We purpose to place secure, highly effective, and easy X-ray know-how within the arms of pressing care facilities, sports activities groups, residence care, and worldwide mission operations, the place a real-time prognosis is vital to saving human lives.”

MARKET SNAPSHOT

OXOS first acquired FDA clearance for its Micro C System in 2021. Final yr, it acquired one other FDA 510(okay) clearance for the system that included its AiLARA System, an AI-automated radiation dosage engine.

Accessing imaging in low- to middle-income international locations could be troublesome. OXOS is pitching its device as a option to permit extra people worldwide to entry X-ray imaging know-how.

One other firm working to make imaging units extra moveable is Philips, which created Lumify, a handheld ultrasound transducer that may be plugged right into a smartphone or a pill and dropped at a affected person’s bedside. 

Darren Mann, Kathryn Kuttler and Dr. Peter Haug will supply extra element through the HIMSS23 session “Improved Affected person Care Enabled by Actual-Time Interoperable Medical Choice Assist.” It’s schedule for Thursday, April 20 at 4 p.m. – 5 p.m. CT on the South Constructing, Stage 1, room S105 C.

About Author

Leave a Reply

Your email address will not be published. Required fields are marked *